BSC
HUMA icon

BOLTON SECURITIES CORPORATION’s Humacyte HUMA Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.96K Buy
+4,000
New +$7.84K ﹤0.01% 1631
2025
Q1 		$6.82K Buy
+4,000
New +$15K ﹤0.01% 1505

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's HUMA Position: Q3 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Humacyte (HUMA) in Q3 2025: 4,000 shares worth $6.96K. The stake represents ﹤0.01% of the portfolio and ranks #1631 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in HUMA as recently as Q1 2025.

BOLTON SECURITIES CORPORATION first reported a position in HUMA in Q1 2025 and has held it in 2 quarters since. 142 funds tracked by Wall St. Rank hold HUMA as of Q3 2025.

  • BOLTON SECURITIES CORPORATION held 4,000 shares of Humacyte worth $6.96K as of Q3 2025.
  • Humacyte was a new BOLTON SECURITIES CORPORATION position in Q3 2025.
  • Humacyte made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2025, its #1631 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Humacyte in Q1 2025 and has held it in 2 quarters since.
  • 142 funds tracked by Wall St. Rank held Humacyte as of Q3 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2025, filed 12 Nov 2026.